Literature DB >> 2806739

Language and neurodevelopmental outcome of low-birthweight infants at three years.

B R Vohr1, C Garcia-Coll, W Oh.   

Abstract

Forty low-birthweight (LBW) infants (28 AGA, 12 SGA) and 16 fullterm infants have been followed for three years with neurological, developmental, language, behavior and audiometric assessments. Only two (5 per cent) of the LBW infants were neurologically abnormal at three years. The AGA infants continued to lag cognitively and in receptive language in comparison with the fullterm infants. Socio-economic factors had a significant effect on the language development of all three groups. Short gestation and neurological status at eight months continued to have a significant effect on language performance. A variety of behavioral characteristics correlated with cognitive and language scores, and impaired middle-ear status was associated with lower cognitive function. These data support the concept that language development of LBW infants is influenced by perinatal, neurological and socio-economic factors, and by behavioral characteristics and middle-ear status.

Entities:  

Mesh:

Year:  1989        PMID: 2806739     DOI: 10.1111/j.1469-8749.1989.tb04043.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  The long-term prognosis of pre-term infants: conceptual, methodological, and ethical issues.

Authors:  Linda S Siegel
Journal:  Hum Nat       Date:  1994

2.  Cognitive development in low risk preterm infants at 3-4 years of life.

Authors:  B Caravale; C Tozzi; G Albino; S Vicari
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-06-14       Impact factor: 5.747

3.  Stability and change of IQ scores in preschool children diagnosed with autistic spectrum disorder.

Authors:  Claudine Dietz; Sophie H N Swinkels; Jan K Buitelaar; Emma van Daalen; Herman van Engeland
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-03-30       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.